Treatment Intensification in Vulnerable Populations: ARPI Use in Elderly, Frail, and High-Comorbidity Patients With mCSPC: With Martin Schoen, MD, and Andrew W. Hahn, MD

Treatment Intensification in Vulnerable Populations: ARPI Use in Elderly, Frail, and High-Comorbidity Patients With mCSPC: With Martin Schoen, MD, and Andrew W. Hahn, MD

Featuring Martin W. Schoen, MD, MPH, Andrew W. Hahn, MD

Watch Now
Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD

Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD

Featuring David O'Malley, MD

Watch Now
Unlocking the Power of ctDNA for Residual Disease, Resistance Monitoring, and Real-Time Treatment Decisions in GI Cancers: With Christopher Lieu, MD

Unlocking the Power of ctDNA for Residual Disease, Resistance Monitoring, and Real-Time Treatment Decisions in GI Cancers: With Christopher Lieu, MD

Featuring Christopher Lieu, MD

Watch Now

Shorts

The Potential Effect of Daraxonrasib for Pancreatic Cancer Management
1:18
The Potential Effect of Daraxonrasib for Pancreatic Cancer Management
an hour ago
by
Shubham Pant, MD, MBBS
Elizabeth Jaffee, MD
1:31
Examining a Novel Vaccine in Pancreatic Cancer
a day ago
by
Elizabeth Jaffee, MD
BTG Lung
1:52
Discussing the Biggest Unmet Needs to be Addressed at 2026 BTG Lung
a day ago
by
Caroline Seymour(+1 more)
Johannes Schetelig, MD, MSc
2:02
ATLG vs PTCy as GVHD Prophylaxis in Hematologic Malignancies
2 days ago
by
Johannes Schetelig, MD, MSc
Yeon Hee Park, MD, PhD
1:03
Outlining the Rationale for an ASCENT-07 Subgroup Analysis in Breast Cancer
3 days ago
by
Yeon Hee Park, MD
Shimoli Barot, MD
1:02
Spotlighting the FDA Approval of Palbociclib Plus Trastuzumab for HER2+ Breast Cancer
3 days ago
by
Shimoli Barot, MD
Elizabeth Jaffee, MD, Johns Hopkins
1:16
Exploring the Potential Role of Cancer Vaccines in Pancreatic Cancer
3 days ago
by
Elizabeth Jaffee, MD
Marc S. Hoffmann, MD
1:35
Breaking Down Zanubrutinib Plus Sonrotoclax in MCL and Next Steps for the Combination
6 days ago
by
Marc S. Hoffmann, MD
Matthew Galsky, MD, Mount Sinai
0:22
Explaining the Significance of the FDA Approval of Pembro Plus EV in MIBC
6 days ago
by
Matthew D. Galsky, MD
Diwakar Davar, MBBS, MSc
0:42
Targeting PRAME in Melanoma
7 days ago
by
Diwakar Davar, MD